Lombardo, N.; D’Ecclesia, A.; Chiarella, E.; Pelaia, C.; Riccelli, D.; Ruzza, A.; Lobello, N.; Piazzetta, G.L.
Real-World Evaluation of Dupilumab in the Long-Term Management of Eosinophilic Chronic Rhinosinusitis with Nasal Polyps: A Focus on IL-4 and IL-13 Receptor Blockade. Medicina 2024, 60, 1996.
https://doi.org/10.3390/medicina60121996
AMA Style
Lombardo N, D’Ecclesia A, Chiarella E, Pelaia C, Riccelli D, Ruzza A, Lobello N, Piazzetta GL.
Real-World Evaluation of Dupilumab in the Long-Term Management of Eosinophilic Chronic Rhinosinusitis with Nasal Polyps: A Focus on IL-4 and IL-13 Receptor Blockade. Medicina. 2024; 60(12):1996.
https://doi.org/10.3390/medicina60121996
Chicago/Turabian Style
Lombardo, Nicola, Aurelio D’Ecclesia, Emanuela Chiarella, Corrado Pelaia, Debbie Riccelli, Annamaria Ruzza, Nadia Lobello, and Giovanna Lucia Piazzetta.
2024. "Real-World Evaluation of Dupilumab in the Long-Term Management of Eosinophilic Chronic Rhinosinusitis with Nasal Polyps: A Focus on IL-4 and IL-13 Receptor Blockade" Medicina 60, no. 12: 1996.
https://doi.org/10.3390/medicina60121996
APA Style
Lombardo, N., D’Ecclesia, A., Chiarella, E., Pelaia, C., Riccelli, D., Ruzza, A., Lobello, N., & Piazzetta, G. L.
(2024). Real-World Evaluation of Dupilumab in the Long-Term Management of Eosinophilic Chronic Rhinosinusitis with Nasal Polyps: A Focus on IL-4 and IL-13 Receptor Blockade. Medicina, 60(12), 1996.
https://doi.org/10.3390/medicina60121996
